1.
Association of CDX2 expression and overall survival and clinicopathologic disease manifestations in patients with gastric cancer in Northwest of Iran

Farideh Akbari , Zohreh Ghoreishi , Mohammad Asghari Jafarabadi , Khatereh Rezazadeh , Babak Nejati, Ali Esfahani*

Immunopathol Persa. 2019;5(1): e03. doi: 10.15171/ipp.2019.03

Scopus ID: 85149038252

Article

PDF

XML

Cited By:

Original

2. Exploring RDW as a predictive marker for 5-year overall and progression-free survival in breast cancer; a retrospective, diagnostic cohort study

Ali Mir , Marzieh Lashkari , Ehsan Habibi*

Immunopathol Persa. 2026;12(2): e43883. doi: 10.34172/ipp.2025.43883

Article

PDF

XML

Cited By:

Meta-analysis

3. Systematic review and meta-analysis of hypofractionated and conventional fractionated radiotherapy on survival in breast cancer patients

Azadeh Haghiri , Jayran Zebardast , Atieh Akbari , Maryam Kalantari Khandani , Majid Shakiba , Naeimeh ShahrabiFarahani , Mohammad Esmaeil Akbari* , Mohammad Eslami

Immunopathol Persa. 2026;12(2): e44001. doi: 10.34172/ipp.2026.44001

Article

PDF

XML

Cited By:

1. Association of CDX2 expression and overall survival and clinicopathologic disease manifestations in patients with gastric cancer in Northwest of Iran

2. Exploring RDW as a predictive marker for 5-year overall and progression-free survival in breast cancer; a retrospective, diagnostic cohort study

3. Systematic review and meta-analysis of hypofractionated and conventional fractionated radiotherapy on survival in breast cancer patients

1.
Association of CDX2 expression and overall survival and clinicopathologic disease manifestations in patients with gastric cancer in Northwest of Iran